Breast Cancer
Metastatic Right Breast Carcinoma
Female, 46 years
Patient Internal ID: 75731448
ICD-10 code
C50.9 Malignant Neoplasm of Breast of Unspecified Site
Diagnosis (Incl. Metastases/Stage) and Year
March 2019
Right Breast Carcinoma cT3N1M1 G2, ER+, PR+, HER2(-), BRCA2+ stage IV. Multiple Metastases to Bone, Lung.
Disease progression in June 2020 – Metastases in Liver.
Previous Treatment
Radiation Therapy, Target Therapy (Denozumab), Hormone Therapy (Tamoxifen), Hormone Therapy (Gosselin), Chemotherapy (Paclitaxel), Chemotherapy (Capecitabine), Chemotherapy (Carboplatin).
Prognosis and Survival Expectation
The prognosis remains poor for Advanced Breast Cancer, with a median survival of around 32 months from diagnosis.
Treatment Provided
Autologous DCV (1 dose) and CIK (4 doses) over a period of 3 months
Patient Survival/Condition and Year
Date of Review: 30/12/2023
The patient survived for 21 months from the diagnosis. The patient passed away during the Immunotherapy treatment and did not finish the full treatment schedule. Therefore, no conclusions can be made regarding the effectiveness of the treatment.
